Nektar Therapeutics logo

Nektar Therapeutics

A biopharmaceutical company developing therapeutics for treating cancer, auto-immune disease, and chronic pain using their chemistry technology platform.

1

Funding Rounds

$25.0m

Money raised

Overview

A biopharmaceutical company developing therapeutics for treating cancer, auto-immune disease, and chronic pain using their chemistry technology platform.

Funding series

Funding Series Analysis

The company Nektar Therapeutics has raised a total of $25m in funding over 1 rounds.

Key Insights:

  • Nektar Therapeutics funding round, August 2013: $25m
Nektar Therapeutics logo
Nektar Therapeutics funding round, August 2013 $25m

Industries

Nektar Therapeutics is active in the following industries:
  • Healthcare
  • Biopharmaceutical
  • Biomedical engineering
  • Pharmaceutical industry
  • Engineering
  • Technology
  • Biology
  • Biotechnology
  • Immunology